HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Marelli, L. Articles by Burroughs, A. K. Search for Related Content PubMed PubMed Citation Articles by Marelli, L. Articles by Burroughs, A. K.

Transarterial Injection of ¹³¹I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer

¹ The Sheila Sherlock Hepatobiliary-Pancreatic and Liver Unit, Royal Free Hospital, London, United Kingdom; ² Department of Nuclear Medicine, Royal Free Hospital, London, United Kingdom; ³ Department of Radiology, Royal Free Hospital, London, United Kingdom; and ⁴ Department of Oncology, Royal Free Hospital, London, United Kingdom

View larger version (15K): [in this window] [in a new window]   FIGURE 1.  Survival curves in 131I-lipiodol group, compared with TACE/TAE group.

View larger version (14K): [in this window] [in a new window]   FIGURE 2.  Survival curves in patients with patent portal vein in 131I-lipiodol group, compared with TACE/TAE group.

View larger version (12K): [in this window] [in a new window]   FIGURE 3.  Survival curve in patients with PVT in 131I-lipiodol group, compared with TACE/TAE group (log rank P = 0.0255).